The Hospital Acquired Infections Therapeutics Market is set to expand from $13.5 billion in 2023 to
The Hospital Acquired Infections Therapeutics Market encompasses the industry dedicated to developing and providing treatments aimed at combating infections acquired within healthcare settings. It includes antibiotics, antivirals, antifungals, and advanced therapeutic solutions such as monoclonal antibodies and phage therapy. This market supports efforts to reduce infection rates, improve patient outcomes, and address antibiotic resistance challenges, thereby enhancing healthcare quality and safety.